grace targeted therapies lung cancer 2021 - current treatment options for egfr fusions e.g. rad 51
Published 2 years ago • 21 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
20:32
grace targeted therapies lung cancer 2021 - ros current therapies, emerging treatment options
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
17:53
grace targeted therapies lung cancer 2021 - genotype directed therapy: role in earlier stage disease
-
14:33
grace targeted therapies lung cancer 2021 - targeted therapies in oligo-metastatic disease
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
22:44
grace targeted therapies lung cancer 2021 - new therapies: ntrk, ret and her2
-
3:06
grace targeted therapies lung cancer 2021 - tki plus chemotherapy as a firstline treatment in ros1?
-
2:43
grace targeted therapies in lung cancer 2021 - opinions on various costs and treatment options
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
17:58
grace targeted therapies lung cancer 2021 - kras directed therapies: a new horizon
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
2:43
nrg1 fusions: treatment options - targeted therapies in lung cancer 2023
-
2:01
grace targeted therapies lung cancer 2021 - data learned from ensartinib for ros1 in clinical trial?
-
3:59
grace targeted therapies lung cancer 2021 - treatment options available for kras k12c mutation?